Bank of New York Mellon Corp Sells 566,602 Shares of CME Group Inc. $CME

Bank of New York Mellon Corp decreased its position in CME Group Inc. (NASDAQ:CME) by 10.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,790,233 shares of the financial services provider’s stock after selling 566,602 shares during the quarter. Bank of New York Mellon Corp’s holdings in CME Group were worth $1,294,273,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Amundi lifted its holdings in CME Group by 24.0% during the 2nd quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock worth $548,150,000 after purchasing an additional 385,225 shares during the last quarter. Alley Investment Management Company LLC increased its position in shares of CME Group by 86.0% in the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock worth $7,896,000 after purchasing an additional 13,512 shares during the period. Elevate Capital Advisors LLC increased its holdings in CME Group by 85.2% in the 3rd quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after buying an additional 3,919 shares during the period. Victory Financial Group LLC increased its stake in CME Group by 310.2% in the second quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock valued at $839,000 after acquiring an additional 2,302 shares during the last quarter. Finally, Chicago Capital LLC increased its stake in shares of CME Group by 583.8% in the 3rd quarter. Chicago Capital LLC now owns 13,327 shares of the financial services provider’s stock valued at $3,601,000 after purchasing an additional 11,378 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total transaction of $263,530.00. Following the completion of the sale, the director owned 1,091 shares in the company, valued at $287,511.23. The trade was a 47.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Terrence A. Duffy sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total value of $6,738,750.00. Following the transaction, the chief executive officer directly owned 65,804 shares in the company, valued at $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

CME has been the topic of several research reports. Argus decreased their price target on shares of CME Group from $308.00 to $295.00 in a report on Friday, October 31st. Bank of America boosted their target price on shares of CME Group from $201.00 to $209.00 in a report on Wednesday, December 10th. The Goldman Sachs Group decreased their price target on shares of CME Group from $265.00 to $264.00 and set a “sell” rating for the company in a research report on Wednesday, January 14th. Raymond James Financial lifted their price target on shares of CME Group from $307.00 to $311.00 and gave the stock an “outperform” rating in a report on Monday, January 5th. Finally, Barclays increased their price objective on CME Group from $280.00 to $304.00 and gave the company an “equal weight” rating in a report on Friday, December 12th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, CME Group presently has an average rating of “Hold” and an average price target of $292.18.

CME Group Stock Up 0.2%

CME Group stock opened at $284.48 on Wednesday. The company has a market capitalization of $102.58 billion, a PE ratio of 27.57, a PEG ratio of 3.20 and a beta of 0.27. CME Group Inc. has a 12-month low of $232.32 and a 12-month high of $290.79. The firm’s fifty day moving average is $274.37 and its 200 day moving average is $272.05. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend was Friday, December 12th. CME Group’s dividend payout ratio is 48.45%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.